Basel, 2017-11-01 - Ulf Grawunder invited for a presentation at the 2017 European Antibody Congress
Ulf Grawunder, CEO and founder of NBE-Therapeutics was invited to present an update on NBE-Therapeutics' ADC development activities at the 2017 European Antibody and World Immunotherapy Congress in Basel, Switzerland
Ulf Grawunder, CEO of NBE-Therapeutics, has been invited to present an update on NBE-Therapeutics ADC Development capabilities at the 2017 European Antibody and World Immunotherapy congress orgnaized by Terrapin. This congress is one of the leading congresses in Europe in the therapeutic antibody development field. Ulf Grawunder's presentation will focus on new data with ADC products conjugated to novel, highly potent anthracycline based toxins. Ulf's presentation was scheduled for the afternoon of Nov. 1, from 3:15-3:35 p.m.
The link to the conference web-site is http://www.terrapin.com/conference/european-antibody-congress/index.stm
Recent news feed
RSS feed from: